http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0454172-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f8cfa5aee4410611b5c562275c9f8e3 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D259-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 |
filingDate | 1990-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62d419125ac5b642596180d1ec403f07 |
publicationDate | 1992-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H0454172-A |
titleOfInvention | New cyclic amine compound and glutamic acid receptor blocking agent |
abstract | NEW MATERIAL:A compound of formula I (R is hydrophobic acyl; l, m, p and q are each 2-4; n is 0-2). n EXAMPLE: 2,4-Dioxo-3-(l-naphthylacetylamino)l,5,8,12-tetrazacyclotetradecane. n USE: A glutamic acid receptor blocking agent. Useful as a therapeutic medicine for neurotransmission inhibition and encephalopathy. n PREPARATION: The objective compound of the formula I can be obtained by condensation reaction between a cyclic amine of formula 3 and a carboxylic acid of formula 4. For said reaction, a conventional amide linkage formation process (for example, a carboxylic acid is made into its acid chloride) can be used. The molar ratio of the compound of the formula 3 to the compound of the formula 4 is pref. >1. n COPYRIGHT: (C)1992,JPO&Japio |
priorityDate | 1990-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.